Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
More than a year after entering into a consent decree over a far-reaching manufacturing scandal, Ranbaxy Laboratories has agreed to pay $500 million to settle criminal and civil charges associated with the episode. In announcing the settlement, the US Department of Justice calls this the “largest” financial penalty paid by a generic drugmaker for violating the Food, Drug & Cosmetic Act. Here are the terms: the Ranbaxy US unit pleaded guilty to three felony counts of violating the Food, Drug & Cosmetic Act and four felony counts of knowingly making material false statements to the FDA. A criminal fine of $130 million will be paid, along with a forfeiture of another $20 million. The drugs in question were made in two plants in Paonta Sahib and Dewas, India.
Help employers find you! Check out all the jobs and post your resume.